Heart Rate Variability Biofeedback for Smoking Cessation Treatment

Phase 2 Completed 28 enrolled Rutgers, The State University of New Jersey National Institute on Drug Abuse (NIDA) · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to conduct an open trial examining the feasibility and acceptability of an adapted heart rate variability biofeedback and smoking cessation treatment that was using a primarily virtual remote intervention.

Timeline

Start: 2021-11-29
Primary completion: 2023-06-15
Completion: 2023-06-15

Publications

Background Leyro TM, Buckman JF, Bates ME. Theoretical implications and clinical support for heart rate variability biofeedback for substance use disorders. Curr Opin Psychol. 2019 Dec;30:92-97. doi: 10.1016/j.copsyc.2019.03.008. Epub 2019 Apr 2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Nicotine patch	Unknown	—	Other

Heart Rate Variability Biofeedback for Smoking Cessation Treatment

Summary

Timeline

Publications

Drugs

Indications